(Q39067776)

8 September 2017

MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. (English)

1 reference

cervical squamous cell carcinoma

8 September 2017

1 reference

1 reference

1 reference

Yiran Chen

1

1 reference

8 September 2017

Guihao Ke

2

1 reference

8 September 2017

Duo Han

3

1 reference

8 September 2017

Shanhui Liang

4

1 reference

8 September 2017

Gong Yang

5

1 reference

8 September 2017

Xiaohua Wu

6

1 reference

8 September 2017

language of work or name

English

0 references

publication date

31 October 2013

1 reference

Experimental Cell Research

8 September 2017

1 reference

8 September 2017

320

1 reference

8 September 2017

1

1 reference

8 September 2017

12-20

1 reference

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Concurrent chemotherapy and radiation: a major advance for women with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Role for a bidentate ribonuclease in the initiation step of RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Mammalian microRNAs: a small world for fine-tuning gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

MicroRNAs and their regulatory roles in animals and plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

microRNA involvement in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Involvement of protein kinase C-delta in DNA damage-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Overexpression of protein kinase Cdelta enhances cisplatin-induced cytotoxicity correlated with p53 in gastric cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Comparison of effects of growth factors and protein kinase C activators on cellular sensitivity to cis-diamminedichloroplatinum(II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

Tumor promotion by depleting cells of protein kinase C delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.10.014

10.1016/J.YEXCR.2013.10.014

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference